| | Title | Author(s) | Year | View Count | | 1 |  | Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma | Hui, MKC; Lai, KKY; Chan, KW; Luk, JM; Lee, NP; Chung, Y; Cheung, LC; Srivastava, G; Tsao, SW; Tang, JC; Law, S | 2012 | 91 |
| 2 |  | Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers | Cao, DX; Li, ZJ; Jiang, XO; Lum, YL; Khin, E; Lee, NPY; Wu, GH; Luk, JMC | 2012 | 24 |
| 3 |  | Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide | Sun, S; Lee, D; Lee, NP; Pu, JKS; Wong, STS; Lui, WM; Fung, CF; Leung, GKK | 2012 | 104 |
| 4 | | Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines. | Sun, S; Wong, TS; Zhang, XQ; Pu, JK; Lee, NP; Day, PJ; Ng, GK; Lui, WM; Leung, GK | 2012 | 298 |
| 5 | | Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: A retrospective cohort study | Liu, AM; Yao, TJ; Wang, W; Wong, KF; Lee, NP; Fan, ST; Poon, RTP; Gao, C; Luk, JM | 2012 | 97 |
| 6 | | Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma | Fatima, S; Lee, NP; Tsang, FH; Kolligs, FT; Ng, IOL; Poon, RTP; Fan, ST; Luk, JM | 2012 | 135 |
| 7 | | Implications of the use of eukaryotic translation initiation factor 5A (eIF5A) for prognosis and treatment of hepatocellular carcinoma | Shek, HP; Fatima, S; Lee, NPY | 2012 | 23 |
| 8 | | Regulation of T Helper 17 by Bacteria: An Approach for the Treatment of Hepatocellular Carcinoma | Sung, YJC; Lee, NPY; El-Nezamy, HS | 2012 | 10 |
| 9 | | Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma | Hui, MKC; Lai, KKY; Chan, KW; Luk, JM; Lee, NP; Chung, Y; Cheung, LCM; Srivastava, G; Tsao, SW; Tang, JC; Law, S | 2012 | 121 |
| 10 | | Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma | Ivanovska, I; Zhang, C; Liu, AM; Wong, KF; Lee, NP; Lewis, P; Philippar, U; Bansal, D; Buser, C; Scott, M; Mao, M; Poon, RTP; Fan, ST; Cleary, MA; Luk, JM; Dai, H | 2011 | 94 |
| 11 | | Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy | Lu, WJ; Lee, NP; Kaul, SC; Lan, F; Poon, RTP; Wadhwa, R; Luk, JM | 2011 | 337 |
| 12 | | Dickkopfs and Wnt/β-catenin signalling in liver cancer | Fatima, S; Lee, NPY; Luk, JMC | 2011 | 101 |
| 13 | | Cytoplasmic Forkhead Box M1 (FoxM1) in Esophageal Squamous Cell Carcinoma Significantly Correlates with Pathological Disease Stage | Hui, MKC; Chan, KW; Luk, JM; Lee, NP; Chung, Y; Cheung, LCM; Srivastava, G; Tsao, SW; Tang, JC; Law, S | 2011 | 132 |
| 14 | | Clinicopathologic and gene expression parameters predict liver cancer prognosis | Hao, K; Lamb, J; Zhang, C; Xie, T; Wang, K; Zhang, B; Chudin, E; Lee, NP; Mao, M; Zhong, H; Greenawalt, D; Ferguson, MD; Ng, IO; Sham, PC; Poon, RT; Molony, C; Schadt, EE; Dai, H; Luk, JM | 2011 | 112 |
| 15 | | Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin | Lu, WJ; Lee, NP; Kaul, SC; Lan, F; Poon, RTP; Wadhwa, R; Luk, JM | 2011 | 205 |
| 16 | | Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting | Lamb, JR; Zhang, C; Xie, T; Wang, K; Zhang, B; Hao, K; Chudin, E; Fraser, HB; Millstein, J; Ferguson, M; Suver, C; Ivanovska, I; Scott, M; Philippar, U; Bansal, D; Zhang, Z; Burchard, J; Smith, R; Greenawalt, D; Cleary, M; Derry, J; Loboda, A; Watters, J; Poon, RTP; Fan, ST; Yeung, C; Lee, NPY; Guinney, J; Molony, C; Emilsson, V; BuserDoepner, C; Zhu, J; Friend, S; Mao, M; Shaw, PM; Dai, H; Luk, JM; Schadt, EE | 2011 | 164 |
| 17 | | DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival | Luk, JM; Burchard, J; Zhang, C; Liu, AM; Wong, KF; Shek, FH; Lee, NP; Fan, ST; Poon, RT; Ivanovska, I; Philippar, U; Cleary, MA; Buser, CA; Shaw, PM; Lee, CN; Tenen, DG; Dai, H; Mao, M | 2011 | 52 |
| 18 | | Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma | Lee, NP; Tsang, FH; Shek, FH; Mao, M; Dai, H; Zhang, C; Dong, S; Guan, XY; Poon, RTP; Luk, JM | 2010 | 584 |
| 19 | | Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma | Lee, NP; Poon, RTP; Shek, FH; Ng, IOL; Luk, JM | 2010 | 532 |
| 20 | | Proteomics of hepatocellular carcinoma: Serum vimentin as a surrogate marker for small tumors (≤2 cm) | Sun, S; Poon, RTP; Lee, NP; Yeung, C; Chan, KL; Ng, IOL; Day, PJR; Luk, JM | 2010 | 374 |
|
